On Medicare Limiting Coverage for Alzheimer’s Drug

January 14, 2022

Biogen’s outrageous original price for Aduhelm, $56,000 per year, is the poster child for how dysfunctional our drug pricing system has become and it is the perfect example of why Medicare should be negotiating drug prices with the pharmaceutical industry. If the administration takes no action, Medicare recipients will continue to see their biggest premium increase in history, all because of Biogen’s greed. That cannot be allowed to happen.

Read the source article at Home – CounterPunch.org
2022-01-12 00:20:18

Share This Story!